We intend to focus our search on target businesses operating in the business services, consumer, healthcare, technology, wellness or sustainability sectors. 

We are a bank holding company headquartered in Anniston, Alabama. We operate primarily through our wholly-owned subsidiary, Southern States Bank, an Alabama banking corporation formed in 2007. The Bank is a full service community banking institution, which offers an array of deposit, loan and other banking-related products and services to businesses and individuals in our […]

We intend to focus our search on the farming and agricultural sectors, including farming-related operations and businesses that support the farming industry, where our management team has extensive experience. (Incorporated in Delaware) David Gladstone is our CEO, president and chief investment officer (CIO). He founded The Gladstone Companies in 2001. (Note: Gladstone Acquisition Corp. priced […]

We are a new blank check company whose sponsor is affiliated with Mubadala Capital, which was established in 2011 as the asset management arm of Mubadala Investment Company PJSC, an Abu Dhabi government-owned sovereign investor, with more than $243 billion of assets under management. (Blue Whale Acquisition Corp. I is incorporated in the Cayman Islands.) We intend […]

(Note: NOT an IPO. This is a NASDAQ uplisting from the OTCQX Market. Our shares are traded on the OTCQX under the symbol “OCBI.” On July 28, 2021, the last reported sales price for our common stock on the OTCQX was $33.60 per share. We have applied to list our common stock on the NASDAQ Capital […]

Healthwell Acquisition Corp. I is a newly incorporated blank check company, incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target […]

We are a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. These disorders often occur when neurons are overly excited or inhibited, leading to an imbalance, and our focus is on restoring […]

We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. We are developing our lead product candidate, ADG20, for the treatment and prevention of coronavirus disease 2019, or COVID-19, the disease caused by the virus SARS-CoV-2 and its variants. COVID-19 has caused the current global pandemic that remains a […]

(Note: Healthcare Royalty, Inc. postponed its IPO indefinitely “due to market conditions” on Friday morning, Aug. 6, 2021, the day that the IPO was initially expected to start trading on the NASDAQ.) We are the leading mid-market royalty acquisition company, based upon the number of transactions and aggregate value of capital deployed since 2016. We […]

We are the largest and the fastest-growing franchisor and operator of out-of-home (OOH) waxing services in the United States by number of centers and system-wide sales. We delivered over 21 million waxing services in 2019 and over 13 million waxing services in 2020, generating more than $687 million and $469 million of system-wide sales, respectively, […]